The Role of Support Groups in The Elimination of Viral Hepatitis

Conference on Liver Disease in Africa (COLDA) 2019

Assessment of Awareness and Knowledge of Low And Middle-Income Populations (Lmics) on Viral Hepatitis

Conference on Liver Disease in Africa (COLDA) 2019

Awareness and Advocacy creation

Conference on Liver Disease in Africa (COLDA) 2019

Eight Week Hepatitis C Virus Treatment with Sobosfovir Based Regimen is Effective in People Who Inject Drugs within 6 months of treatment Despite Non-Adherence to Lab and Clinic Follow-up

Conference on Liver Disease in Africa (COLDA) 2019

Successful treatment of Hepatitis C among people who inject drugs in Nairobi, Kenya.

Conference on Liver Disease in Africa (COLDA) 2019

A same day screen, test and treat model for chronic HCV and HBV infection: Results from two community-based pilot studies

Conference on Liver Disease in Africa (COLDA) 2019

Prevalence of Fatty Liver Disease and Associated Factors Among Outpatients Attending Internal Medicine Clinics at Muhimbili University of Health and Allied Sciences Academic Medical Centre, Tanzania

Conference on Liver Disease in Africa (COLDA) 2019

Factors Associated with Liver Toxicity Among HIV Infected Children and Adolescents Attending a National Referral Pediatric HIV Clinic in Uganda

Conference on Liver Disease in Africa (COLDA) 2019

HCC developed following DAAs treatment does not display more aggressive pattern

Conference on Liver Disease in Africa (COLDA) 2019

Heading toward hepatitis C virus elimination: Tunisian experience, achievements and prospects

Conference on Liver Disease in Africa (COLDA) 2019

Assessment of Liver Fibrosis after Direct-Acting Antiviral Therapy in Compensated and Decompensated HCV-related Liver Diseases

Conference on Liver Disease in Africa (COLDA) 2019

Efficacy of Direct-Acting Antiviral (DAA) Regimens In HIV/HCV-co-Infected Patients in Libya

Conference on Liver Disease in Africa (COLDA) 2019

Hepatitis C treatment among People who Inject drugs in Kenya: Preliminary findings of the Test and Link to Care for injecting Drug Users Study

Conference on Liver Disease in Africa (COLDA) 2019

High rates of HBV functional cure among HIV/HBV-coinfected patients on ART in Zambia

Conference on Liver Disease in Africa (COLDA) 2019

Analysis of The National Hepatitis B Viral Load Testing Programme in Uganda

Conference on Liver Disease in Africa (COLDA) 2019

Prenatal consultation as a starting point for family screening of hepatitis B virus, the CI cohort ANRS 12359.

Conference on Liver Disease in Africa (COLDA) 2019

Risk factors for viral hepatitis C infection in Rwanda: Results from a Nationwide Screening Program

Conference on Liver Disease in Africa (COLDA) 2019

Prevalence of Hepatitis B Surface Antigen (HBsAg) Positivity and its Associated Factors in Rwanda

Conference on Liver Disease in Africa (COLDA) 2019

NASH/NAFLD as Cause for HCC - Helen Reeves, MD, PhD

European Workshop on NASH in Clinical Practice 2019

Patient Perspective - Teresa Casanovas, MD and Maite Pujol

European Workshop on NASH in Clinical Practice 2019

Future Treatment and Management Options - Vlad Ratziu, MD, PhD

European Workshop on NASH in Clinical Practice 2019

NASH and Immune-Mediated Diseases - Maria Teresa Arias Loste, MD, PhD

European Workshop on NASH in Clinical Practice 2019

Cardiovascular Risk in NAFLD - Jorn M. Schattenberg, MD

European Workshop on NASH in Clinical Practice 2019

Drug-Induced Liver Injury and NASH - Raul Andrade, MD, PhD

European Workshop on NASH in Clinical Practice 2019